Connor Clark & Lunn Investment Management Ltd. Invests $202,000 in The Clorox Company $CLX

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of The Clorox Company (NYSE:CLX) during the second quarter, HoldingsChannel reports. The institutional investor purchased 1,682 shares of the company’s stock, valued at approximately $202,000.

A number of other hedge funds also recently added to or reduced their stakes in CLX. Simplicity Wealth LLC lifted its holdings in shares of Clorox by 157.3% during the 2nd quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock valued at $2,199,000 after buying an additional 11,198 shares during the period. Raymond James Financial Inc. increased its position in Clorox by 15.6% during the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock valued at $39,747,000 after acquiring an additional 36,352 shares during the last quarter. Nordea Investment Management AB lifted its holdings in Clorox by 16.3% in the second quarter. Nordea Investment Management AB now owns 484,352 shares of the company’s stock valued at $57,827,000 after acquiring an additional 68,026 shares during the period. AlphaQuest LLC boosted its position in Clorox by 109.4% in the first quarter. AlphaQuest LLC now owns 11,873 shares of the company’s stock worth $1,748,000 after purchasing an additional 6,203 shares during the last quarter. Finally, Swedbank AB grew its stake in shares of Clorox by 18.0% during the 2nd quarter. Swedbank AB now owns 192,504 shares of the company’s stock valued at $23,114,000 after purchasing an additional 29,420 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Trading Up 4.0%

Shares of CLX stock opened at $104.09 on Friday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The stock has a fifty day simple moving average of $115.29 and a two-hundred day simple moving average of $122.38. The firm has a market capitalization of $12.70 billion, a PE ratio of 15.96, a PEG ratio of 0.92 and a beta of 0.52. The Clorox Company has a 52-week low of $98.20 and a 52-week high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the previous year, the business earned $1.86 earnings per share. The business’s revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s dividend payout ratio (DPR) is 77.86%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on CLX shares. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Clorox from $128.00 to $121.00 and set a “hold” rating on the stock in a research note on Tuesday, November 4th. Wells Fargo & Company reduced their price objective on Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a research note on Tuesday, November 4th. Rothschild & Co Redburn lowered their target price on Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Finally, JPMorgan Chase & Co. cut their price target on Clorox from $127.00 to $120.00 and set a “neutral” rating for the company in a report on Tuesday, November 4th. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have given a Sell rating to the stock. According to MarketBeat.com, Clorox presently has an average rating of “Reduce” and an average price target of $125.69.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.63% of the stock is currently owned by insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.